Neumega / Oprelvekin

Modified on 2009/10/14 21:46 by admin
Neumega, also known as oprelvekin, is manufactured by Wyeth-Ayerst Pharmaceuticals and is often administered to cancer patients. While Neumega does not treat cancer, it is used to help the body produce platelets, which assist in blood clotting. If platelet counts are too low, a patient may suffer from excessive bleeding leading to death.

Many cancer-fighting drugs destroy interleukin-11, a substance produced by the body which helps make platelets. Neumega is a synthetic version of interleukin-11. Recently, Wyeth-Ayerst warned doctors not to prescribe Neumega to children as the drug may lead to a dangerous eye condition known as papilledema.

See a doctor if your child has experienced serious health problems after taking Neumega. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Cancer Drugs: Overview
  2. papilledema: Overview
  Name Size